These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16136965)

  • 1. [Expression of S100 protein in renal cell carcinoma and its relation with P53].
    Yang JF; Zhang XY; Qi F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):301-4. PubMed ID: 16136965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 expression in kidney tubules adjacent to renal cell carcinoma: evidence of a precursor lesion.
    Lai R; el Dabbagh L; Mourad WA
    Mod Pathol; 1996 Jun; 9(6):690-5. PubMed ID: 8782209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A1: a powerful marker to differentiate chromophobe renal cell carcinoma from renal oncocytoma.
    Li G; Barthelemy A; Feng G; Gentil-Perret A; Peoc'h M; Genin C; Tostain J
    Histopathology; 2007 Apr; 50(5):642-7. PubMed ID: 17394501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 isoforms in renal cell carcinoma.
    Song W; Huo SW; Lü JJ; Liu Z; Fang XL; Jin XB; Yuan MZ
    Chin Med J (Engl); 2009 Apr; 122(8):921-6. PubMed ID: 19493415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of Skp2 and p27kip1 expression in human renal cell carcinoma using tissue chip technique].
    Yao C; Zheng SB; Wu P; Zhang HJ; Jiang YD; Chen T; Qi H; Zhao GZ; Zhao JF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):642-5. PubMed ID: 18495610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 and HER-2 alterations in renal cell carcinoma.
    Zhang XH; Takenaka I; Sato C; Sakamoto H
    Urology; 1997 Oct; 50(4):636-42. PubMed ID: 9338750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53 oncoprotein and bcl-2 in renal cell carcinoma.
    Uzunlar AK; Sahin H; Yilmaz F; Ozekinci S
    Saudi Med J; 2005 Jan; 26(1):37-41. PubMed ID: 15756350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma.
    Baytekin F; Tuna B; Mungan U; Aslan G; Yorukoglu K
    Urol Oncol; 2011; 29(5):502-7. PubMed ID: 19945306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of IGF-IR and COX-2 in renal cell carcinoma and their relationship with cell proliferation].
    Sun H; Wang H; Qin WJ; Yang B; Wang SC; Jian BL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):348-50. PubMed ID: 19351509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p53 in renal carcinoma cells is independent of pVHL.
    Stickle NH; Cheng LS; Watson IR; Alon N; Malkin D; Irwin MS; Ohh M
    Mutat Res; 2005 Oct; 578(1-2):23-32. PubMed ID: 15998523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
    J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
    Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
    Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
    Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
    Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
    Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of p53 expression, cellular proliferation, and DNA content as prognostic indicators in renal cell carcinoma.
    Papadopoulos I; Rudolph P; Weichert-Jacobsen K
    Eur Urol; 1997; 32(1):110-7. PubMed ID: 9266242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
    Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
    BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calponin h1 expression in renal tumor vessels: correlations with multiple pathological factors of renal cell carcinoma.
    Islam AH; Ehara T; Kato H; Hayama M; Kobayashi S; Igawa Y; Nishizawa O
    J Urol; 2004 Mar; 171(3):1319-23. PubMed ID: 14767341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine interleukin-6 production in renal cell carcinoma: evidence for the involvement of p53.
    Angelo LS; Talpaz M; Kurzrock R
    Cancer Res; 2002 Feb; 62(3):932-40. PubMed ID: 11830554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of GRP78 in renal cell carcinoma and its significance.
    Fu W; Wu X; Li J; Mo Z; Yang Z; Huang W; Ding Q
    Urology; 2010 Mar; 75(3):603-7. PubMed ID: 19616278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of Fas expression alteration during tumor progression of renal cell carcinoma.
    Sejima T; Miyagawa I
    Int J Urol; 2006 Mar; 13(3):257-64. PubMed ID: 16643620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.